## **Core Concept**
The pulmonary hyaline membrane, also known as hyaline membrane disease (HMD) or respiratory distress syndrome (RDS), is a leading cause of morbidity and mortality in preterm infants. This condition arises due to the immaturity of the lungs, specifically the lack of surfactant production, which leads to difficulty in lung expansion and gas exchange.

## **Why the Correct Answer is Right**
The correct answer, **preterm infants**, is right because pulmonary hyaline membrane disease is most commonly associated with preterm birth. Preterm infants have underdeveloped lungs that lack sufficient surfactant, a substance that reduces the surface tension in the lungs, allowing them to expand properly during breathing. Without enough surfactant, the lungs collapse, making it difficult for the infant to breathe, and leading to the formation of hyaline membranes in the airspaces.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, options might include terms like "term infants," "children," or "adults." These are incorrect because pulmonary hyaline membrane disease is specifically associated with preterm infants due to their lung immaturity.
- **Option B:** Similarly, this option is not provided but would likely refer to a different population or condition not directly related to the specific context of pulmonary hyaline membrane disease in perinatal mortality.
- **Option D:** This option is also not provided but would presumably be incorrect for similar reasons as option A, not directly relating to the established risk factor of prematurity for pulmonary hyaline membrane disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that antenatal corticosteroid administration to mothers at risk of preterm delivery can significantly reduce the incidence and severity of respiratory distress syndrome (RDS) in preterm infants by accelerating fetal lung maturation and surfactant production.

## **Correct Answer:** . preterm infants